Bringing you news, analysis and commentary on drug policy and politics from the UK and around the world.
Find out more at https://www.volteface.me
Volteface
Claim This Podcast5.0(4 reviews)
10 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇬🇧
Podcast Overview
Bringing you news, analysis and commentary on drug policy and politics from the UK and around the world. Find out more at https://www.volteface.me
Language
🇺🇲
Publishing Since
12/10/2021
Reach the team behind Volteface
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
March 13, 2024
Drug Policy News Show: Ben Sessa, Dutch updates, Oregon roll back, France removes medical
Enjoyable News Show this week with @KowalskiKatya for @VoltefaceHub - plenty of contraversy and more of a 'drug policy' focus this week 🚨 Ben Sessa barred in sex scandal: 01:00 🇳🇱 Dutch cannabis pilot bad news: 09:30 🍃 Teeside cannabis club update: 16:00 ☹️ Oregon to roll back decrim policies: 19:00 🇫🇷 France removing flower from medical market: 31:00 🇩🇪 German artist advertises medical cannabis: 40:00
March 6, 2024
Industry News Show - 06/03/24
<p><a href='https://www.linkedin.com/feed/'>Volteface</a> Industry news show with <a href='https://www.linkedin.com/feed/'>Katya Kowalski</a></p> <p>We discuss:</p> <p><a href='https://www.linkedin.com/feed/'>CB1 Medical</a> recent price increase (now dropped)</p> <p><a href='https://www.linkedin.com/feed/'>Medisonal</a> opens making the total clinic count 43!!</p> <p><a href='https://www.linkedin.com/feed/'>Script Assist</a> launch 'Find a Doctor'</p> <p><a href='https://www.linkedin.com/feed/'>Ananda Developments Plc</a> announce a new trial</p> <p><a href='https://www.linkedin.com/feed/'>Curaleaf</a> and <a href='https://www.linkedin.com/feed/'>GROW® Pharma </a>Media Watch</p> <p> </p> <p>Thanks for watching!</p>
April 13, 2023
Has German cannabis reform taken a step backwards?
<p>In this episode Paul and Katya discuss the recent German governments revised cannabis policy and explore if this is a good thing or a step backwards.</p> <p> </p> <p>To follow our work check out <a href='http://www.volteface.me'>www.volteface.me</a> and subscribe for more drug policy content.</p> <p> </p> <p> </p>
10 total episodes available
Deep-dive analytics for Volteface
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Volteface?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.